Developing long-acting growth hormone formulations

被引：27
|
作者：
Cawley, Pippa [1 ]
Wilkinson, Ian [1 ]
Ross, Richard J. [1 ]
机构：
[1] Univ Sheffield, Acad Unit Diabet Endocrinol & Reprod, Sheffield S10 2RX, S Yorkshire, England
来源：
CLINICAL ENDOCRINOLOGY | 2013年 / 79卷 / 03期
关键词：
PREPARATION NUTROPIN DEPOT; GH PREPARATION; PHARMACODYNAMIC CHARACTERISTICS; FACTOR-I; PHARMACOKINETICS; CHILDREN; EFFICACY; LB03002; FUSION; SAFETY;
D O I：
10.1111/cen.12240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Daily recombinant growth hormone (GH) restores normal growth and body composition in GH-deficient children and adults; however, daily injections are inconvenient and can be distressing for some children. On top of this compliance is a problem in up to 75% of children. Developing long-acting GH formulations has proved challenging, and questions remain regarding safety and efficacy. In this review, we focus on the rationale for generating long-acting GH agonists and the technologies being developed to deliver prolonged exposure to GH.
引用
收藏
页码：305 / 309
页数：5
相关论文
共 50 条
  • [1] Long-Acting Growth Hormone
    Charlotte Höybye
    Jens Sandahl Christiansen
    Pediatric Drugs, 2013, 15 : 427 - 429
  • [2] Long-Acting Growth Hormone
    Hoybye, Charlotte
    Christiansen, Jens Sandahl
    PEDIATRIC DRUGS, 2013, 15 (06) : 427 - 429
  • [3] Long-acting growth hormone in 2022
    Steiner Margaret
    Frank Jacklyn
    Saenger Paul
    儿科学研究（英文）, 2023, 07 (01)
  • [4] Long-Acting Growth Hormone: An Update
    Saenger, Paul H.
    Mejia-Corletto, Jorge
    ADVANCED THERAPIES IN PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY, 2016, 30 : 79 - 97
  • [5] Long-acting growth hormone in 2022
    Steiner, Margaret
    Frank, Jacklyn
    Saenger, Paul
    PEDIATRIC INVESTIGATION, 2023, 7 (01) : 36 - 42
  • [6] Issues and challenges in developing long-acting veterinary antibiotic formulations
    Sun, YC
    Scruggs, DW
    Peng, YX
    Johnson, JR
    Shukla, AJ
    ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (10) : 1481 - 1496
  • [7] Long-Acting Growth Hormone for Replacement Therapy
    Johannsson, Gudmundur
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (06): : 1668 - 1670
  • [8] Long-acting microneedle formulations
    Vora, Lalitkumar K.
    Sabri, Akmal H.
    Naser, Yara
    Himawan, Achmad
    Hutton, Aaron R. J.
    Anjani, Qonita Kurnia
    Volpe-Zanutto, Fabiana
    Mishra, Deepakkumar
    Li, Mingshan
    Rodgers, Aoife M.
    Paredes, Alejandro J.
    Larran, Eneko
    Thakur, Raghu Raj Singh
    Donnelly, Ryan F.
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 201
  • [9] Growth hormone receptor agonists and antagonists: From protein expression and purification to long-acting formulations
    Wang, Yue
    Kim, Minah
    Buckley, Chantal
    Maynard, Heather D. D.
    Langley, Ries J. J.
    Perry, Jo K. K.
    PROTEIN SCIENCE, 2023, 32 (09)
  • [10] Comparing treatment with daily and long-acting growth hormone formulations in adults with growth hormone deficiency: Challenging issues, benefits, and risks
    Hoybye, Charlotte
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (06)
12345